Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Net Cash Flow (2018 - 2025)

Avai Bio's Net Cash Flow history spans 6 years, with the latest figure at -$615.0 for Q1 2024.

  • On a quarterly basis, Net Cash Flow fell 100.69% to -$615.0 in Q1 2024 year-over-year; TTM through Mar 2024 was -$107191.0, a 244.5% decrease, with the full-year FY2025 number at $80772.0, up 175.35% from a year prior.
  • Net Cash Flow hit -$615.0 in Q1 2024 for Avai Bio, down from -$584.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for AVAI hit a ceiling of $88660.0 in Q1 2023 and a floor of -$106954.0 in Q2 2023.
  • Historically, Net Cash Flow has averaged -$2068.1 across 4 years, with a median of $189.0 in 2023.
  • The widest YoY moves for Net Cash Flow: up 2354.25% in 2020, down 10666.42% in 2020.
  • Tracing AVAI's Net Cash Flow over 4 years: stood at -$14476.0 in 2020, then surged by 203.07% to $14921.0 in 2022, then plummeted by 103.91% to -$584.0 in 2023, then decreased by 5.31% to -$615.0 in 2024.
  • Business Quant data shows Net Cash Flow for AVAI at -$615.0 in Q1 2024, -$584.0 in Q4 2023, and $962.0 in Q3 2023.